ID

36864

Beschrijving

Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2; ODM derived from: https://clinicaltrials.gov/show/NCT02229734

Link

https://clinicaltrials.gov/show/NCT02229734

Trefwoorden

Versies (1)
  1. 17-06-19 17-06-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

17 juni 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT02229734

Engels

Eligibility Prostate Cancer NCT02229734

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
high risk prostate cancer
Beschrijving

High risk Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0600139
has had multidisciplinary consultation with radiation oncologist and urologist
Beschrijving

Multidisciplinary assessment Radiation Oncologist Urologist

Datatype

boolean

Alias
UMLS CUI [1,1]
C0729737
UMLS CUI [1,2]
C1514693
UMLS CUI [1,3]
C0260314
age >70 or refuses standard treatment
Beschrijving

Age | Standard therapy Refused

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C2936643
UMLS CUI [2,2]
C1705116
no evidence of extra-prostatic disease on screening bone scan and ct scan (non-contrast ct used for ct simulation acceptable)
Beschrijving

Disease Extraprostatic Absent Bone scan | Disease Extraprostatic Absent CT scan

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1517078
UMLS CUI [1,3]
C0332197
UMLS CUI [1,4]
C0203668
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C1517078
UMLS CUI [2,3]
C0332197
UMLS CUI [2,4]
C0040405
signed written and voluntary informed consent provided.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Beschrijving

Protocol Compliance

Datatype

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients not meeting the eligibility criteria
Beschrijving

Inclusion criteria failed

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0231175
prior pelvic radiotherapy or brachytherapy
Beschrijving

Radiotherapy to pelvis | Brachytherapy

Datatype

boolean

Alias
UMLS CUI [1]
C1536155
UMLS CUI [2]
C0006098
use of anti-coagulation (low molecular weight heparin or coumadin)
Beschrijving

Use of anticoagulation | Heparin, Low-Molecular-Weight | Coumadin

Datatype

boolean

Alias
UMLS CUI [1]
C0449867
UMLS CUI [2]
C0019139
UMLS CUI [3]
C0699129
history of inflammatory bowel disease, crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
Beschrijving

Inflammatory Bowel Disease | Crohn Disease | Diverticulitis | Collagen-vascular disease | Exception Rheumatoid Arthritis

Datatype

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0010346
UMLS CUI [3]
C0012813
UMLS CUI [4]
C0262428
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0003873
previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
Beschrijving

Prior Therapy Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
patients on androgen deprivation therapy > 2 months prior to study enrolment
Beschrijving

Antiandrogen therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0279492
Terug naar het begin van de pagina

Similar models

Eligibility Prostate Cancer NCT02229734

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
High risk Prostate carcinoma
Item
high risk prostate cancer
boolean
C0332167 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Multidisciplinary assessment Radiation Oncologist Urologist
Item
has had multidisciplinary consultation with radiation oncologist and urologist
boolean
C0729737 (UMLS CUI [1,1])
C1514693 (UMLS CUI [1,2])
C0260314 (UMLS CUI [1,3])
Age | Standard therapy Refused
Item
age >70 or refuses standard treatment
boolean
C0001779 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Disease Extraprostatic Absent Bone scan | Disease Extraprostatic Absent CT scan
Item
no evidence of extra-prostatic disease on screening bone scan and ct scan (non-contrast ct used for ct simulation acceptable)
boolean
C0012634 (UMLS CUI [1,1])
C1517078 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0203668 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C1517078 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0040405 (UMLS CUI [2,4])
Informed Consent
Item
signed written and voluntary informed consent provided.
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Inclusion criteria failed
Item
patients not meeting the eligibility criteria
boolean
C1512693 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Radiotherapy to pelvis | Brachytherapy
Item
prior pelvic radiotherapy or brachytherapy
boolean
C1536155 (UMLS CUI [1])
C0006098 (UMLS CUI [2])
Use of anticoagulation | Heparin, Low-Molecular-Weight | Coumadin
Item
use of anti-coagulation (low molecular weight heparin or coumadin)
boolean
C0449867 (UMLS CUI [1])
C0019139 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
Inflammatory Bowel Disease | Crohn Disease | Diverticulitis | Collagen-vascular disease | Exception Rheumatoid Arthritis
Item
history of inflammatory bowel disease, crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0012813 (UMLS CUI [3])
C0262428 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0003873 (UMLS CUI [5,2])
Prior Therapy Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
boolean
C1514463 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Antiandrogen therapy
Item
patients on androgen deprivation therapy > 2 months prior to study enrolment
boolean
C0279492 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial